EXOS ASSET MANAGEMENT LLC
Q3 2024 Form 13-F

NEW YORK, DELAWARE
CIK 0001834630 · CRD 305706 · SEC-registered investment adviser
$1.0M Reported Value Total

EXOS ASSET MANAGEMENT LLC reports 2 total accounts under management (AUM). There are 2 discretionary accounts valued at $177,591,371, and 0 non-discretionary accounts.

Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
SEC Registered Discretionary Manager
Private funds (Form ADV)
5 funds · $47.4M gross asset value
Real Estate Fund: $40.0M · Hedge Fund: $6.9M · Private Equity Fund: $547.4K
Source: Form ADV filed 2026-08-13
Reported value
$1.0M
Quarter over quarter
-1.2%
Holdings
57
Top-10 concentration
70.5%

Filing Structure

Reports holdings for

Holdings reported by

Key People

Form ADV owners & control persons
Brady William Dougan
SHAREHOLDER
Robert L Basso
CHIEF ADMINISTRATION OFFICER
Paul David Greene
CHIEF FINANCIAL OFFICER

Filing Navigation

13F Metrics

Loading 13F Metrics

Q3 2024 13F record

Q3 2024 13F filing summary

Q3 2024 Form 13F portfolio summary
Period of report September 30, 2024
Filed November 13, 2024
Form 13F-HR
Reported value $1.0M
Positions 57
Change in reported value -98.8%
New positions 5
Exited positions 91
Position turnover 64.9%
Top-10 concentration 70.5%

13F filings by quarter

Form 13F filings by quarter
Quarter Positions Value
Q3 2025 13F
Filed Nov 13, 2025
0 $0
Q2 2025 13F
Filed Aug 14, 2025
0 $0
Q1 2025 13F
Filed May 15, 2025
2 $2.3K
Q4 2024 13F
Filed Feb 13, 2025
38 $433.4K
Q3 2024 13F
Filed Nov 13, 2024
57 $1.0M
Q2 2024 13F
Filed Aug 14, 2024
144 $87.3M
Q1 2024 13F
Filed May 15, 2024
184 $169.1M
Q2 2022 13F
Filed Aug 12, 2022
297 $192.4M
Q1 2022 13F
Filed Apr 13, 2022
319 $233.5M
Q4 2021 13F
Filed Mar 14, 2022
359 $194.3M
Q3 2021 13F
Filed Oct 25, 2021
454 $189.5M
Q2 2021 13F
Filed Jul 23, 2021
818 $192.6M
Q1 2021 13F
Filed May 5, 2021
429 $127.3M
Q4 2020 13F
Filed Feb 16, 2021
238 $61.1M

Top 20 holdings · Q3 2024

Largest Q3 2024 13F positions by reported value
# Holding Reported value % of portfolio
1 TLSI TRISALUS LIFE SCIENCES INC $178.0K 17.27%
2 LZMWS LIFEZONE METALS LIMITED $117.7K 11.42%
3 VEEAW VEEA INC $73.1K 7.09%
4 IPXXW INFLECTION PT ACQUISITN CRP $72.8K 7.06%
5 AACTWS ARES ACQUISITION CORP II $64.9K 6.3%
6 SLNDWS SOUTHLAND HLDGS INC $55.4K 5.38%
7 SLMWF SLAM CORP $46.8K 4.54%
8 ABLLW ABACUS LIFE INC $42.5K 4.12%
9 SPWRW COMPLETE SOLARIA INC $38.4K 3.73%
10 SDSTW STARDUST PWR INC $37.4K 3.63%
11 XFINW EXCELFIN ACQUISITION CORP $26.3K 2.55%
12 VSTEW VAST RENEWABLES LIMITED $25.7K 2.49%
13 FLDDW FTAC EMERALD ACQUISITION COR $25.7K 2.49%
14 COCHW ENVOY MEDICAL INC $24.8K 2.41%
15 LVROW LAVORO LTD $22.5K 2.18%
16 BRKHW BURTECH ACQUISITION CORP $22.2K 2.15%
17 VSEEW VSEE HEALTH INC $19.6K 1.9%
18 PITAW HERAMBA ELEC PLC $10.1K 0.98%
19 EVGRW EVERGREEN CORPORATION $7.6K 0.73%
20 GHIXW GORES HOLDINGS IX INC $7.5K 0.73%

Values as reported on the Q3 2024 Form 13F. Every position is in the holdings table below.

Filing Details

Loading Activities
Loading Sector Allocation
Crunching numbers

Performance

Loading Performance

Potential New Buys

Finding Potential New Buys

Holdings

Building table
Loading SEC filing data
Loading Form 4 Filings

Beneficial Ownership (Schedule 13D/13G)

Loading 13D/G filings